Home » Topics » BioWorld Science

BioWorld Science
RSS

Impact Biomedical announces development of Quantum antihistamine

July 27, 2022

Discovery of novel candidates for the treatment of Chagas disease

July 27, 2022

ScinnoHub Pharmaceutical discovers plasmin inhibitors

July 27, 2022

CFB inhibitors identified by Shanghai Hengrui Pharmaceutical, Jiangsu Hengrui Medicine

July 27, 2022

Nonessential but critical, tyrosine plays key role in nutrient sensing

July 26, 2022

New compound advances anoctamin-1 inhibition for analgesia

July 26, 2022

RNF31 as a novel therapeutic target for immunotherapy-refractory cancers

July 26, 2022

Oryzon collaborates with CMTRF to evaluate HDAC6 inhibitors for Charcot-Marie-Tooth disease

July 26, 2022

PsychoGenics to evaluate preclinical antiseizure efficacy of IAMA's selective NKCC1 inhibitors

July 26, 2022

Altamira Therapeutics to develop OligoPhore-based AM-411 for rheumatoid arthritis

July 26, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...